drugset / Trial / NCT00003165

Doxorubicin in Treating Women With Advanced Breast Cancer

NCT00003165 ↗

Phase 2 Unknown 25 enrolled University of Glasgow
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different forms may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of doxorubicin in treating women with advanced metastatic breast cancer.

Timeline

Start
1997-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject PK1 Unknown — Intravenous

Indications